BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
The main method of fighting against colon cancer is targeted treatment. BRAF inhibitors, which are accepted as standard treatment for V600E mutant malign melanomas, are the newest approach for targeted treatment of V600E mutant colorectal cancers. In this case report, we share our experience about t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925159/ https://www.ncbi.nlm.nih.gov/pubmed/29850361 http://dx.doi.org/10.1155/2018/8782328 |